Rank #1250IONS

Ionis Pharmaceuticals, Inc.

$83.14

1.13% (Daily)

Market Cap

$13.47B

Revenue

$966.96M

Rank by MCap

#1250

Sector

Healthcare

Industry

Biotechnology

CEO

Dr. Brett P. Monia Ph.D.

Headquarters

Carlsbad, CA

Employees

1,069

About Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company offers TRYNGOLZA reduces triglyceride levels in adults with familial chylomicronemia syndrome (FCS) and acute pancreatitis; WAINUA for the treatment of the polyneuropathy of hereditary transthyretin-medicated amyloidosis (ATTRv-PN) in adults; and SPINRAZA for pediatric and adult patients with spinal muscular atrophy (SMA). It also provides QALSODY for the tr...